Goldman, Butterwick, Fitzpatrick and Groff
gbfg.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
41
Active
12
Phase 3
5
Total enrollment
939
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine | — | — | — | — | — | 1 | |
| Left leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine | — | — | — | — | — | 1 | |
| Sham Comparator | — | — | — | — | 2 | ||
| Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy | — | — | — | — | — | 1 | |
| Left Arm treated with vehicle serum and Intense Pulsed Light Therapy | — | — | — | — | — | 1 | |
| CE Ferulic | — | — | — | — | — | 1 | |
| Babor Ultimate ECM Repair Serum | — | — | — | — | — | 1 | |
| Babor Cure Cream | — | — | — | — | — | 1 | |
| Pavise Serum | — | — | — | — | — | 1 | |
| On GLP1 plus HRT | — | — | — | — | — | 1 | |
| On GLP1 Only | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2025-03-05
- 2026-05-30
- 2026-07-30
- 2026-08-30
- 2026-11-10
Top conditions
- Wrinkle5
- Skin Laxity4
- Laxity; Skin3
- Photodamaged Skin2
- Leg Veins2
- Adiposity1
- Improve Photoaging Signs1
- Actinic Keratoses1
Frequently asked questions about Goldman, Butterwick, Fitzpatrick and Groff
- How many clinical trials does Goldman, Butterwick, Fitzpatrick and Groff have on ClinicalTrials.gov?
- Goldman, Butterwick, Fitzpatrick and Groff is listed as the lead sponsor on 41 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Goldman, Butterwick, Fitzpatrick and Groff's trials are in Phase 3?
- 5 of Goldman, Butterwick, Fitzpatrick and Groff's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Goldman, Butterwick, Fitzpatrick and Groff focus on?
- Goldman, Butterwick, Fitzpatrick and Groff's most-studied conditions on ClinicalTrials.gov are Wrinkle, Skin Laxity, Laxity; Skin, Photodamaged Skin, Leg Veins.
- When are Goldman, Butterwick, Fitzpatrick and Groff's next clinical trial readouts?
- Goldman, Butterwick, Fitzpatrick and Groff has 6 upcoming primary-completion readouts tracked here; the soonest is “Skin Care Regimen for Improving Photoaging Signs on the Face”, expected around 2024-12-31.